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Bone morphogenetic proteinsThe roof plate resident BMPs have sequential functions in the developing spinal cord, establishing cell fate and
orienting axonal trajectories. These activities are, however, restricted to the dI1–dI3 neurons in the most
dorsal region of the spinal cord. What limits the extent of the action of the BMPs to these neurons? To address
this question, we have examined both the distribution of the inhibitory Smads (I-Smads), Smad6 and Smad7
in the spinal cord and the consequence of ectopically expressing the I-Smads in chicken embryos. Our studies
suggest that the I-Smads function in vivo to restrict the action of BMP signaling in the dorsal spinal cord.
Moreover, the I-Smads have distinct roles in regulating the diverse activities of the BMPs. Thus, the ectopic
expression of Smad7 suppresses the dI1 and dI3 neural fates and concomitantly increases the number of dI4–
dI6 spinal neurons. In contrast, Smad6 most potently functions to block dI1 axon outgrowth. Taken together,
these experiments suggest that the I-Smads have distinct roles in spatially limiting the response of cells to
BMP signaling.Way, University of Southern
l rights reserved.© 2011 Elsevier Inc. All rights reserved.Introduction
A critical paradigm in developmental biology is the use of graded
distributions of inductive growth factors, or morphogens, to pattern
ﬁelds of cells. Morphogens are used reiteratively, in a concentration
dependent manner, to specify cellular identity (Ulloa and Briscoe,
2007). Recent studies have also demonstrated that, in addition to the
speciﬁcation of diverse cell fates, morphogens can also direct multiple
cellular processes within a developing organism (Augsburger et al.,
1999; Charron et al., 2003; Irving et al., 2002; Lyuksyutova et al.,
2003). An example of this paradigm is the role of members of the Bone
Morphogenetic Protein (BMP) family in establishing neural identity in
the dorsal spinal cord (Lee et al., 1998; Liem et al., 1997) and then
directing the orientation (Butler and Dodd, 2003) and growth rate
(Phan et al., 2010) of axons extending from the dorsal-most
commissural neurons. BMPs, in combination with activins, both
members of the Transforming Growth Factor (TGF) β superfamily, act
from the roof plate at the dorsal midline of the spinal cord to specify
the fate of the dorsal-most spinal neurons, dorsal interneuron (dI) 1 to
dI3 (Chizhikov and Millen, 2005). The remainder of the dorsal spinal
cord is thought to form independently of signals from the roof plate:
the dI4–dI6 neurons are still present after either ablation of the roof
plate (Lee et al., 2000) or BMP receptor (Bmpr) signaling (Timmeret al., 2002;Wine-Lee et al., 2004). However, Bmprs are present in the
dorsal progenitor (dP) 4–dP6 neurons (Yamauchi et al., 2008) and
explants taken from the early intermediate chick spinal cord can be
directed by the BMPs to form dI1 neurons (Liem et al., 1997)
suggesting that the intermediate progenitors are initially competent
to respond to signals from the roof plate. These studies raise the
question, what limits the action of signals from the roof plate to
speciﬁc groups of dorsal neurons? Here, we present evidence that the
endogenous inhibitors of TGFβ signaling, the inhibitory Smad
(I-Smad) proteins, Smad6 and Smad7, have a role in this process.
The activities of the BMPs are mediated by a heterodimeric
complex of type I and type II BMP serine/threonine kinase receptors.
On BMP binding, the type I Bmprs activate the receptor-activated
Smads (R-Smads) (Moustakas and Heldin, 2009) which oligomerize
with the common-mediator Smad (Co-Smad) Smad4 (Chesnutt et al.,
2004; Feng and Derynck, 2005). The Smad complex then translocates
to the nucleus to act as a transcriptional regulator (Heldin et al., 1997).
BMP signaling can be blocked by the action of Smad6 and Smad7
(Imamura et al., 1997; Nakao et al., 1997). I-Smads have been shown
to inhibit BMP or TGFβ signaling in vitro by several mechanisms
(Moustakas and Heldin, 2009), which include competing with the
R-Smads for binding to the type I BMP receptor (Goto et al., 2007;
Hayashi et al., 1997; Imamura et al., 1997; Kamiya et al., 2010; Nakao
et al., 1997; Souchelnytskyi et al., 1998), competing with Smad4 for
R-Smad binding (Hata et al., 1998) or cooperating in the induction of
type I BMP receptor degradation (Kavsak et al., 2000; Murakami et al.,
2003). The extent to which certain activities are common to the
I-Smads or unique to a speciﬁc I-Smad remains unclear.
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cell fate speciﬁcation and guidance activities of the BMPs in the dorsal
spinal cord (Lee et al., 1998; Liem et al., 1997; Yamauchi et al., 2008).
Although the Smads have been implicated in the regulation of both
cell fate speciﬁcation and neurite outgrowth/regeneration in other
systems (Moustakas and Heldin, 2009; Parikh et al., 2011; Yanagisawa
et al., 2001; Zou et al., 2009), their role in mediating BMP signaling
in the developing spinal cord remains unresolved. Previous studies
have shown that Smad4 is critical for pattern formation in the dorsal
neural tube (Chesnutt et al., 2004) however the function of the
R-Smads and I-Smads has not been determined. Here, we investigate
whether Smad6 and Smad7 regulate BMP signaling in vivo. Our studies
in developing chicken embryos have shown that the I-Smads have
different expression patterns in the spinal cord and are able to block
distinct activities of the BMPs. Smad7 is present in newly differentiating
neurons in the intermediate spinal cord and, when mis-expressed
dorsally, blocks the acquisition of the dorsal interneuron (dI)1 and dI3
fates and results in a dorsal expansion of dI4–dI6 fates. In contrast,
Smad6 is most highly expressed in mature neurons in the dorsal and
intermediate spinal cord and, when ectopically expressed, inhibits dI1
axon outgrowth. Together, these studies suggest that the I-Smads act to
endogenously limit the extent of BMP/activin signaling in the
developing spinal cord and that different I-Smads can block speciﬁc
activities of the BMPs.
Materials and methods
In situ hybridization and immunohistochemistry
Antibody staining and in situ hybridization histochemistry were
performed on 20–30 μm transverse sections from Hamburger and
Hamilton (HH) stages 10–27 (Hamburger and Hamilton, 1992) chick
and Embryonic (E)13 rat spinal cords and dissociated dorsal neurons
from E13 rat embryos as previously described (Augsburger et al.,
1999). Fluorescence and differential interference contrast images
were collected on a Carl Zeiss LSM510 confocal and Axiovert 200 M
and Axioplan 2 microscopes. Images were quantiﬁed and processed
using Adobe Photoshop CS4.
Chick Cath1 (Ben-Arie et al., 1996), Cash1 (Jasoni et al., 1994),
Smad6, Smad7a and Smad7b (Vargesson and Laufer, 2009) in situ
probes were made from linearized plasmids using a DIG RNA labeling
kit (Roche).
Antibodies against the following proteins were used. Rabbit: Lhx2/9
(panLh2a/b), 1:1000 (Liemet al., 1997); Islet1/2 (K5), 1:2000 (Tsuchida
et al., 1994); GFP 1:1000 (Invitrogen); Pax2, 1:250 (Invitrogen); Smad6
1:100 (Cell Signaling Technology); pSmad1/5/8, 1:1000 (a generous gift
from Ed Laufer), Mafb 1:2000 (Eichmann et al., 1997). Mouse: Msx1/2
1:5 (Developmental Studies Hybridoma Bank); Pax6, 1:5 (Develop-
mental Studies Hybridoma Bank); p27 (Kip1), 1:250 (BD Transduction
Laboratories), FLAG (M2), 1:1000 (Sigma). Goat: Pax3, 1:250 (R&D
Systems); Sox2, 1:1000 (Santa Cruz Biotechnology); Isl1 1:2000 (R&D
Systems); Guinea pig: Ngn2, 1:16,000 (Skaggs et al., 2011). Sheep: GFP
1:2000 (Biogenesis). Species appropriate Cyanine 3 and Fluorescein
conjugated secondary antibodies were used (Jackson ImmunoResearch
Laboratories).
Expression constructs and in ovo electroporation
Expression constructs encoding Smad6 or Smad7 under the control
of the CMV enhancer have been described by the Miyazono group
(Ebisawa et al., 2001; Imamura et al., 1997). Expression constructs
containing either Smad6 or Smad7 were fused to the Math1 enhancer
(Helms et al., 2000) in combination with an IRES-farnesylated (f) GFP
cassette as previously described (Yamauchi et al., 2008).
FertileWhite Leghorn eggs (AA Laboratory Eggs, Westminster, CA)
were incubated to HH stages 10–16. The following expressionconstructs were electroporated into the developing neural tube as
previously described (Briscoe et al., 2000): CMV::GFP (0.2 μg/μl),
CMV::Smad6 (1.8 μg/μl), CMV::Smad7 (1.8 μg/μl), Math1::fGFP
(0.2 μg/μl), Math1::Smad6-IRES-fGFP (3 μg/μl), and Math1::Smad7-
IRES-fGFP (3 μg/μl). All statistical analyses were performed using a
two-tailed Student's t-test.
Results
I-Smads are expressed in dynamic patterns in the developing spinal cord
The chicken genome contains a single Smad6 gene and two Smad7
genes, Smad7a and Smad7b (Vargesson and Laufer, 2009) which are
96% identical at the amino acid level. To investigate whether these
I-Smads have a role in the speciﬁcation of the dorsal spinal cord, we
ﬁrst examined whether Smad6 and Smad7a/b are present in the
developing embryonic chicken spinal cord. We examined the expres-
sion pattern of the I-Smadgenes fromHamburgerHamilton (HH) stages
10 to 27 (Hamburger and Hamilton, 1992) the period during which the
fate of the dorsal populations of neurons, dI1–dI6 are speciﬁed (Gross
et al., 2002; Helms and Johnson, 2003; Muller et al., 2002) and the dI1
commissural axon trajectory is established (Holley et al., 1982).
Using in situ hybridization and immunohistochemistry, we were
unable to detect I-Smad gene expression during the early stages of the
speciﬁcation of the dorsal spinal cord, HH stages 10–18 (data not
shown), suggesting that the I-Smads have no functional role at these
stages. However, both Smad6 and Smad7were present at slightly later
stages of dorsal neural development, from HH stage 22 on, albeit in
distinct patterns. At HH stage 23, Smad6 is expressed at low levels in
many post-mitotic cells in the spinal cord (Fig. 1D). By HH stage 27,
Smad6 resolves to be present at high levels only in differentiated
neurons in the dorsal spinal cord (Fig. 1G). At this stage, the
expression pattern of Smad6 substantially overlaps with themigrating
Lhx2/9+ dI1 neurons (Supplemental Fig. 4), suggesting that Smad6 is
present in dI1 neurons. The protein distribution of Smad6 in both the
rodent spinal cord (Figs. 1J–L) and dissociated dorsal neurons
(Figs. 1M–O) conﬁrms that it is present on the processes of spinal
neurons (Figs. 1K and O) including the Tag1+ dI1 axons (Fig. 1J).
Intriguingly, Smad6 appears to be present at the highest levels on axons
in the ventral funiculus (arrowheads, Fig. 1L), a position consistentwith
the contralaterally projecting dI1 commissural axons (arrowhead,
Supplemental Fig. 4B).
In contrast, at HH stage 23, Smad7a is expressed at the highest
levels in the intermediate spinal cord in newly born neurons at the
boundary between the ventricular zone, where the progenitor cells
are differentiating, and the mantle layer, where the post-mitotic
neurons reside (arrowheads, Fig. 1E). These newly differentiated
neurons have positions consistent with being from the dP4–dP6 and
ventral p0–p2 progenitor cell populations (Figs. 1C and E). At HH
stage 27, Smad7a is still present in newly born neurons in the ventral
spinal cord (arrowheads, Fig. 1H) but is also up-regulated in the
dorsal-most region of the ventricular zone (bracket, Fig. 1H). Smad7b
is expressed at very low levels throughout the spinal cord at HH stage
23 (Fig. 1F) and at higher levels throughout the spinal cord at HH
stage 27 (Fig. 1I). The dynamic expression patterns of the I-Smads
suggest that they may inhibit the disparate effects of BMP mediated
signaling, cell fate speciﬁcation and axon guidance.
Ectopic expression of I-Smads in chicken embryos inhibits the acquisition
of dorsal cell fate
Since little is known about the ability of the I-Smads to terminate
BMP signaling in vivo, we examined the consequence of mis-expressing
either Smad6 or Smad7 by in ovo electroporation of chicken embryos.
Mouse Smad6 and Smad7 were used in these experiments; these
proteins are 71% and 88%/87% identical to chicken Smad6 and Smad7a/b
Fig. 1. Inhibitory Smads have dynamic expression patterns during early spinal cord development. (A–C) Transverse sections of the spinal cord taken from HH stage 23 chicken
embryos labeled with antibodies against Lhx2/9 (A), Isl1/2 (B) and Pax2 (C) to establish the positions of dI1, dI3 and dI4 populations of dorsal interneurons (dotted brackets).
(D–I) In situ hybridization experiments for Smad6 (D and G), Smad7a (E and H) and Smad7b (F and I) on sections of the spinal cord taken from either HH stage 23 (D, E and F) or
HH stage 27 (G, H and I) chicken embryos. (D and G) Although Smad6 is broadly expressed in post-mitotic spinal neurons at HH stage 23, expression resolves to dorsal post-
mitotic neurons by HH stage 27. (E and H) Smad7a is expressed at the highest levels in differentiating spinal neurons in the intermediate and ventral spinal cord at both HH stages 23
and 27 (arrowheads). At HH stage 27, Smad7a is also expressed in dorsal neural progenitors (dotted bracket, H). (F and I) Smad7b is expressed throughout the spinal cord with the
highest levels at HH stage 27. (J–O) Antibodies against Smad6 (red, J–M and O) label neural processes in transverse sections (J–L) and Tuj1+ (green, M and N) dissociated dorsal
neurons (M–O) taken fromE13 rat spinal cords. Smad6 is co-expressed in the Tag1+ (green) dI1 (commissural) axons in the dorsal spinal cord (J) and is present at the highest levels on
the contralaterally projecting commissural axons (compare arrowheads in L to the arrowhead in Supplemental Fig. 4B). Panel L is a highermagniﬁcation view of the boxed region in K.
Scale bar: A–L: 25 μm, M–O: 5 μm.
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of Smad7, use of the mouse Smad7 gene circumvented the need to mis-
express two nearly identical forms of chicken Smad7.
We have previously found thatmodulating the activity of the type I
BMP receptors (Bmprs) altered the speciﬁcation of dorsal cell fate
only when Bmpr signaling is disrupted at HH stages 10–12 (Yamauchi
et al., 2008). No fate changes were observedwhen Bmpr signaling was
disrupted at HH stages 14/15 (Yamauchi et al., 2008). This result
suggests that the “window” of competence for dorsal spinal neural
progenitors to be re-speciﬁed by Bmpr signaling is closed by HH stage
15. Thus, we assessedwhether the I-Smads could block the acquisition
of dorsal cell fate in a similar time frame by ectopically expressing
Smad6 or Smad7 throughout the spinal cord at either HH stages 10–12
(Fig. 2E) or HH stages 14–16 (Fig. 2F). Both I-Smad proteins were
observed to be present at high levels throughout the spinal cord
following electroporation at either stage (Supplemental Fig. 1 and
data not shown). Electroporated embryos were permitted to develop
to HH stages 24/25 and then examined for dorsal cell fate defects by
assessing the distribution of Cath1 (Atoh1) in dP1 cells (Helms and
Johnson, 1998) and Cash1 in dP3–dP5 cells (Gowan et al., 2001) as
well as the number of Lhx2/9+ dI1 neurons (Lee and Jessell, 1999;
Liem et al., 1997) and Isl1/2+ dI3 neurons (Liem et al., 1997), two of
the dorsal cell types that are dependent on BMP/activin signaling from
the roof plate (Lee et al., 1998; Liem et al., 1997; Timmer et al., 2005).
As a control for this series of experiments, chicken embryos were also
electroporated with CMV::GFP. This construct was never observed to
have a signiﬁcant effect on the development of the spinal cord
(Figs. 2–5 and data not shown).Despite the importance of BMP signaling in the early development
of the spinal cord, the mis-expression of the I-Smads throughout the
spinal cord at HH stages 10–12 had surprisingly modest effects on the
speciﬁcation of dorsal cell fate (Fig. 2E). No signiﬁcant loss of dorsal
spinal neurons was observed following the ectopic expression of
Smad6. Smad7mis-expression resulted in the loss of about 30% of dI1
neurons, but did not have a measurable effect on the number of dI3
neurons (Fig. 2E). These observations may stem from the I-Smads
being unexpectedly ineffective at blocking endogenous R-Smad
signaling at HH stages 10–12 since the electroporation of either
I-Smad did not result in a signiﬁcant loss of R-Smad activity
(Supplemental Fig. 1I).
In contrast, the mis-expression of Smad6 and Smad7 at HH stages
14–16 had far more severe consequences for the identity of the dorsal
spinal cord. Both I-Smads were able to equivalently inhibit the activity
of the R-Smads (Supplemental Figs. 1D, H and I). However, only
the ectopic expression of Smad7 signiﬁcantly affected the domains of
Cath1 and Cash1 expression. The extent of Cath1 was greatly di-
minished (arrowhead, Fig. 2B), and low levels of Cash1 now extended
dorsally to the roof plate (solid bracket, Fig. 2D), suggesting that
Smad7 can suppress the dP1 cell fate, while promoting dP3–dP5 fates.
Examination of post-mitotic neural dorsal markers conﬁrmed that the
ectopic expression of Smad7 more profoundly affects the identity of
the dorsal spinal cord compared to Smad6. The mis-expression of
Smad6 resulted in the loss of 20% of the dI1 neurons (Figs. 2F, I and J)
but had no apparent effect on the number of dI3 neurons (Figs. 2F, O
and P). In contrast, themis-expression of Smad7 causedmajor changes
in the numbers of both dI1 and dI3 neurons. Nearly 80% of the dI1
Fig. 2. Mis-expression of I-Smads differentially affects the fate of dorsal spinal neurons. (A–R) GFP (G, H, M and N), Smad6 (A, C, I, J, O and P) or Smad7 (B, D, K, L, Q and R) were
ectopically expressed throughout the spinal cord under the control of the CMV enhancer by in ovo electroporation at either HH stages 10–12 (E) or HH stages 14–16 (A–D, F–R).
Embryos were harvested at HH stages 24/25 and examined for the extent of Cath1 (A and B) and Cash1 (C and D) expression and the number of Lhx2/9+ commissural (dI1) neurons
(red, G–L) or Isl1/2+ association (dI3) neurons (red, M–R). (A–D) In situ hybridization experiments demonstrated that in ovo electroporation of Smad7 (arrowhead, B), but not
Smad6 (A), greatly reduces the extent of expression of Cath1 expression (A and B) suggesting that dP1 cells have been lost. Cash1 levels were also affected by Smad7 (D), but Smad6
(C), mis-expression, low levels of Cash1 expression were now observed adjacent to the roof plate (compare expression levels in solid brackets to dotted brackets, C and D). The
electroporated side is indicted by +. (E) The ectopic expression of Smad6 from HH stages 10–12 had no effect on the number of either dI1 or dI3 neurons compared to the
electroporation of GFP (dI1, Student's t-test, pN0.53 probability different from GFP+ control, n=107 sections from 8 embryos; dI3, pN0.29, n=50 sections from 5 embryos). In
contrast, themis-expression of Smad7 resulted in a 30% loss of dI1 neurons (pb4.3×10−11, n=72 sections from 4 embryos) but had no effect on the number of dI3 neurons (pN0.70,
n=47 sections from 6 embryos). (F–R) A CMV::GFP construct electroporated into the chick spinal cord at HH stages 14–16 had no observable effect on the number of either Lhx2/9+
dI1 (F, G and H; n=316 sections from 8 embryos) or Isl1/2+ dI3 neurons (F, M and N; n=72 sections from 5 embryos). The mis-expression of Smad6 construct had a weak effect on
cell fate: 20% of dI1 neurons were lost (F, I and J; pb6.4×10−17 probability different from GFP+ control, n=69 sections from 5 embryos) but there was no signiﬁcant effect of mis-
expressing Smad6 on the number of dI3 neurons (F, O and P; pN0.74, n=45 sections from 5 embryos). In contrast, the mis-expression of Smad7 resulted in a profound loss of both
dI1 and dI3 neurons. Over 70% of dI1 neurons were lost (F, K and L; pb2.7×10−131, n=105 sections from 9 embryos) whereas about 50% of dI3 neurons were lost (F, Q and R;
pb2.2×10−11, n=80 sections from 5 embryos) from HH stage 24/25 spinal cords. Scale bar: 25 μm.
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were absent (Figs. 2F, Q and R).
To summarize these results, the I-Smads appear to be most
effective in blocking BMP/activin signaling during a later time period
than the one in which the type I Bmprs specify dorsal fate (Yamauchi
et al., 2008). The I-Smads also appear to have different activities when
mis-expressed, with Smad7 being more successful than Smad6 at
blocking the acquisition of the dorsal-most cell fates in the spinal cord.
Taken together with the endogenous expression pattern of Smad7a,
these results suggest a model in which the presence of Smad7 acts to
limit the action of dorsalizing BMP/activin signals from the roof plate
on newly differentiating neurons in the intermediate spinal cord as
well as later born neural progenitors in the dorsal ventricular zone.
Smad7, but not Smad6, misexpression results in an increase in Pax2+ dI4
neurons
To further assess whether Smad6 or Smad7 has a role in mediating
dorsal cell fate, we determined whether there were compensatoryfate changes in the spinal cord following the electroporation of the
I-Smads at HH stages 14–16 that indicated the fate of the presumptive
dI1 and dI3 neurons. We ﬁrst determined whether there were
increased levels of cell death in the spinal cord following electropo-
ration of CMV::Smad6 and CMV::Smad7. In both cases, the introduc-
tion of either of these constructs had no effect on the number of
apoptotic cells detected by the TUNEL reaction (Supplemental Fig. 2
and data not shown).
We then examinedwhether the overall pattern of the dorsal half of
the spinal cord was altered. We found that there was no observable
effect of electroporation with either CMV::Smad6 or CMV::Smad7 on
the distribution of Mafb, Msx1/2, Pax3 and Pax6, markers of the dorsal
and intermediate spinal cord (Fig. 3). Thus, there did not appear to
be a gross defect in either the formation of the roof plate or the
patterning of dorsal or intermediate spinal neural progenitors. We
also assessed the overall number of both Sox2+ neural progenitors
(Bylund et al., 2003) and p27+ post-mitotic neurons (Novitch et al.,
2001) following mis-expression of the I-Smads. Supporting the
conclusion that the mis-expression of the I-Smads did not result in
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Smad7 (Figs. 4E–H) had no observable effect on the number of Sox2+
or p27+ cells compared to the GFP control (Fig. 4Q).
Finally, we assessed whether there was a compensatory increase in
the number of dorsal neurons thought to form independently of BMP
signaling. Previous studies have shown that the dI4–dI6 populations of
neurons are generated in the absence of either the roof plate or Bmpr
signaling (Lee et al., 2000; Millonig et al., 2000; Wine-Lee et al., 2004).
We thus examinedwhether therewasanalteration in thedistributionof
Ngn2, present in newly differentiating dP2–dP5 neural progenitors, or
Pax2, present in differentiated dI4 and dI6-v1 cells (Burrill et al., 1997;
Gowanet al., 2001;Helms and Johnson, 2003; Zhuang and Sockanathan,
2006). The mis-expression of either GFP or Smad6 had no effect on the
distribution of Ngn2 or Pax2 (Figs. 4I–L and R). In sharp contrast, the
mis-expression of Smad7 resulted in a 15% increase in the number of
Ngn2+ progenitors (solid bracket, Figs. 4M, N and R) and a 20% increase
in the overall number of Pax2+ neurons (Figs. 4O, P and R). Further
inspection showed that the additional Pax2+ neurons predominately
came from the dI4 population of neurons (Fig. 4S) and that these
neurons expanded into a dorsal location that overlappedwith the Isl1+
dI3 population of neurons (solid bracket, Fig. 4P and Supplemental
Fig. 3). There was no signiﬁcant difference in the number of Pax2+Fig. 3. Mis-expression of Smad6 and Smad7 does not affect the distribution of many mar
combination with either Smad6 (A–D and I–L) or Smad7 (E–H and M–P) were ectopically ex
14/15. Embryos were harvested at HH stages 24/25 and examined for the distribution of mark
roof plate cells and post-mitotic MNs, Augsburger et al., 1999), Msx1/2 (C, D, G and H: roof
progenitor neurons, Goulding et al., 1991) or Pax6 (K, L, O and P; p0–p2, pMN progenitor neu
of these markers on the electroporated or non-electroporated side of the spinal cord. ScaledI6-v1 neurons following electroporation with Smad7, Smad6 or GFP
(Fig. 4S).
Thus, the mis-expression of Smad7, but not Smad6, results in the loss
of the BMP/activin dependent spinal neurons and an increase in the
number of dorsal spinal neurons generated independently of signals from
the roof plate. This result strongly supports a model in which Smad7 acts
in newly differentiating neurons in the intermediate spinal cord to block
BMP/activin signaling from the roof plate and thereby enables the
generation of dI4–dI6 spinal neurons.
Smad6, but not Smad7, regulates dI1 axon outgrowth
As development proceeds, Smad6 gene expression is strongly
upregulated in a population of dorsal post-mitotic neurons (Fig. 1G)
and Smad6 protein is present on processes, most notably on the
contralaterally projecting commissural axons (Figs. 1J–L). The position
of many of the Smad6+ cells overlaps with the early-born Lhx2/9+ dI1
commissural neurons, which by HH stage 27 are in the process of
migrating to a deeper location in the intermediate spinal cord
(Supplemental Fig. 4). In contrast, the expression pattern of Smad7a in
the dorsal spinal cord is limited to progenitors in the ventricular zone
and Smad7b is ubiquitously expressed at low levels. Since BMP signalingkers of the roof plate and dorsal and intermediate spinal cord. (A–P) GFP (green) in
pressed throughout the spinal cord under the control of the CMV enhancer at HH stages
ers that broadly demarcate the dorsal and intermediate spinal cord: Mafb (A, B, E and F;
plate and dorsal progenitor neurons,Timmer et al., 2002), Pax3 (I, J, M and N; dP1–dP6
rons, Ericson et al., 1997). There was no observable difference between the distribution
bar: 25 μm.
Fig. 4. Smad7, but not Smad6, mis-expression leads to a compensatory increase in the number of dI4 neurons. (A–P) GFP (green) in combination with either Smad6 (A–D and I–L) or
Smad7 (E–H and M–P) were ectopically expressed throughout the spinal cord under the control of the CMV enhancer at HH stages 14–16. Embryos were harvested at HH stages
24/25 and examined for the number of Sox2+ (A, B, E and F; neural progenitors), p27+ (C, D, G and H; post-mitotic neurons), Ngn2+ (I, J, M and N; dP2–5 progenitors) and Pax2+
(K, L, O and P; post-mitotic dI4 and dI6-v1 neurons) cells in the dorsal half of the spinal cord. The inserts in panels J and N show a magniﬁed view of the most dorsal region of the
spinal cord. Ngn2+ cells are present more dorsally only on the Smad7 electroporated side of the spinal cord (compare solid brackets, J and N). The inserts in panels L and P show a
magniﬁed view of the dI4 population of Pax2+ neurons. Pax2+ cells were present in a more dorsal location only after Smad7 mis-expression (compare solid brackets, L and P).
(Q) There was no signiﬁcant difference in the number of Sox2+ or p27+ cells following electroporation of either CMV::Smad6 (Student's t-test, Sox2: pN0.18, n=19 sections taken
from 5 embryos; p27: pN0.45, n=19 sections taken from 4 embryos) or CMV::Smad7 (Sox2: pN0.59, n=18 sections taken from 4 embryos ; p27: pN0.76, n=13 sections taken
from 4 embryos) compared to the CMV::GFP+ control (Sox2: n=20 sections taken from 3 embryos; p27: n=19 sections taken from 3 embryos). (R) In contrast, there was a
signiﬁcant increase in the number of both Ngn2+ and Pax2+ cells following electroporation of CMV::Smad7 (Student's t-test, Ngn2: pb0.027, n=26 sections taken from 7 embryos;
Pax2: pb0.0012, n=33 sections taken from 7 embryos) but not CMV::Smad6 (Ngn2: pN0.13, n=51 sections taken from 11 embryos; Pax2: pN0.61, n=68 sections taken from 11
embryos) compared to the CMV::GFP+ control (Ngn2: n=54 sections taken from 8 embryos; Pax2: n=66 sections taken from 6 embryos). (S) Further examination of the Pax2+
population showed that the mis-expression of Smad7 resulted in signiﬁcantly more neurons in the more dorsal dI4 Pax2+ cell population compared to the more ventral dI6-v1
Pax2+ population (dI4: pb0.0014 probability of similarity with GFP+ control, n=24 sections from 7 embryos; dI6: pN0.13, n=26 sections from 7 embryos). Scale bar: 25 μm.
571V.M. Hazen et al. / Developmental Biology 356 (2011) 566–575from the roof plate is also required to guide dI1 axons away from the
dorsal midline (Augsburger et al., 1999; Butler and Dodd, 2003), we
assessed whether the distinct expression patterns of the I-Smads might
have a functional consequence in the formation of the dI1 axonal circuit.
Smad6 and Smad7 were ectopically expressed in chicken embryos
under the control of Math1 (Atoh1) enhancer, which speciﬁcally drives
the expression of heterologous genes in differentiated dI1 neurons
(Helms et al., 2000). An IRES-farnesylated (f) GFP cassette was included
in the construct so that the extent of axon outgrowth could be assessed.
Math1::fGFP and Math1::Smad6/7-IRES-fGFP were electroporated at
HH stages 14–16 and the resulting embryos examined at HH stages
22/23. The extent of dI1 axonoutgrowthwasquantiﬁedby assessing thenumber of Lhx2/9+ GFP+ dI1 axons that had reached four arbitrarily
drawn boundaries along the dorsal–ventral axis of the spinal cord, mid-
dorsal (MD), intermediate (INT), mid-ventral (MV) and ﬂoor plate (FP)
(Fig. 5D, Phan et al., 2010).
By HH stage 23, 65% of the control GFP+ dI1 neurons had extended
axons and approximately 40% of these axons had reached the ﬂoor plate
(arrowhead, Figs. 5A and E). Similarly, 75% of the Smad7+ dI1 neurons
extended axons of which 35% had reached the ﬂoor plate (arrowhead,
Figs. 5C and E). In contrast, when Smad6 was ectopically expressed in
dI1 neurons, the axons showed signiﬁcant outgrowth defects. Although
70% of Smad6+ dI1 neurons extended axons, far fewer of these axons,
only 15%, had reached the ﬂoor plate by HH stage 23 (Figs. 5B and E).
572 V.M. Hazen et al. / Developmental Biology 356 (2011) 566–575This result suggests that a key activity of Smad6 in the developing spinal
cord is to regulate axon outgrowth, a previously unknown function for
I-Smad signaling in vivo. Interestingly, this phenotype was not
manifested by all classes of commissural axons, since GFP+ axons
were observed to cross theﬂoor plate following electroporation of CMV::
Smad6 (Figs. 2I and O, 3A, C, I and K, 4A, C, I and K). Thus, the ability of
Smad6 to block axonal outgrowth may be restricted to the dI1 neurons.
In summary, this study suggests that the I-Smads can regulate the
diverse effects of BMP signaling in the spinal cord. However, whereas
Smad7 may primarily inhibit the speciﬁcation of dI1–dI3 cell fate,
Smad6 regulates axonal outgrowth in post-mitotic dI1 neurons.
Discussion
The I-Smads can function to block BMP/activin signaling in the spinal
cord
Although the type I Bmprs (Dewulf et al., 1995; Roelen et al., 1997;
Yamauchi et al., 2008) and Smads (Arnold et al., 2006; Faure et al., 2002;
Flanders et al., 2001 and VMH and SJB, unpublished data) are present
throughout the dorsal spinal cord, only the dorsal-most populations of
spinal neurons require BMP/activin signaling for their identity. What
limits the action of BMP/activin signals from the roof plate to these
neurons? Our studies have suggested a role for Smad7a in this process.
Smad7a is expressed in newly differentiating dorsal neurons in the
intermediate spinal cord from HH stages 22/23 (~3.5 days). The timing
by which dI4–dI6 neurons arise in the chick spinal cord has not been
precisely established, however genetic studies inmouse (Glasgow et al.,
2005; Gross et al., 2002; Helms et al., 2005; Muller et al., 2002) have
suggested that dI4–dI6 neurons start to be born around embryonic
(E) stage 10.5 and continue to be born through stage E11.5. The roughlyFig. 5. Mis-expression of Smad6, but not Smad7, resulted in decreased dI1 commissura
farnesylated (f) GFP under the control of the Math1 enhancer (Math1::fGFP) at HH stage 15,
(B) In contrast, Lhx2/9+ dI1 neurons (red) expressing a Smad6-IRES-fGFP cassette (green
electroporated with a Smad7-IRES-fGFP cassette (green) extend normally to the FP (arrow
determining whether dI1 axons had crossed one of four arbitrary lines in the spinal cord: m
65–75% of Lhx2/9+ neurons electroporated with GFP, Smad6-IRES-fGFP or Smad7-IRES-fGFP
(n=465 sections, taken from 10 embryos) or Smad7 (n=116 sections taken from 5 embryo
of Lhx2/9+ neurons electroporated with Smad6-IRES-fGFP (n=105 sections, taken from 5
pb9.4×10−11). Scale bar: 25 μm.analogous period in chicken embryonic development is from HH stages
18/19 (~3 days) to HH stage 24 (~4 days). Thus, Smad7a starts to be
expressed immediately as the dI4–dI6 neurons are exiting the cell cycle
and is present in differentiating neurons as they emerge from the
intermediate ventricular zone. The timing of Smad7a expression is
therefore consistent with Smad7a having a role ending the ability of
dI4–dI6 neurons to receive patterning information from the roof plate.
Moreover, this result suggests the ﬁnal integration of dorsal patterning
informationmayoccur at the timeof cell cycle exit. Our studies have also
suggested that Smad7 may function endogenously to attenuate the
ability of the BMPs to promote the dI1 fate, which is dependent on the
patterned expression of Atoh1 (Cath1, (Gowan et al., 2001). Atoh1
expression starts to diminish around E12.5 (roughly equivalent to HH
stage 27, (Helms et al., 2000). Thus, the expression of Smad7a in the
dorsal-most neural progenitors from HH stage 27 together with the
ability of Smad7 to potently suppress Cath1 expression strongly
suggests that Smad7a functions to limit the production of dI1 neurons.
We examined the consequence of ectopically expressing the
I-Smads throughout the dorsal spinal cord before they are normally
present. These experiments revealed that Smad7 has the ability to
potently suppress the acquisition of the dorsal-most fates, dI1 and dI3
while promoting the more intermediate dI4 fate. This activity is
consistent with the model that Smad7a functions to establish the dI4
fate by blocking the acquisition of BMP-dependent fates. Moreover, the
results fromour experiments suggested Smad6and Smad7have speciﬁc
roles regulating the different activities of the BMPs. Thus, Smad7 is an
effective inhibitor of the acquisition of the dI1 and dI3 cell fates,whereas
Smad6only has amoremodest effect on the speciﬁcation of dI1 identity.
In contrast, themis-expression of Smad7 had no effect on the extension
of axons, whereas over-expression of Smad6 inhibited dI1 commissural
axon outgrowth. Taken together, these studies suggest that the keyl axon outgrowth. (A) Lhx2/9+ dI1 commissural neurons (red) electroporated with
extend GFP+ axons (green) normally to the ﬂoor plate (FP, arrowhead) by HH stage 23.
) have dramatically reduced axon outgrowth by HH stage 23. (C) Lhx2/9+ dI1 axons
head) by HH stage 23. (D) The extent of the dI1 axon outgrowth was quantiﬁed by
id-dorsal (MD), intermediate (INT), mid-ventral (MV) or the FP. (E) By HH stage 23,
had extended GFP+ axons. Over 35% of these axons had reached the FP in both the GFP
s) mis-expression experiments (probability of similarity, pN0.57). In contrast, only 15%
embryos) had extended to axons to the FP (probability of similarity to GFP control,
573V.M. Hazen et al. / Developmental Biology 356 (2011) 566–575functionof Smad7 in the intermediate spinal cord is to limit the action of
BMP/activin signals from the roof plate, whereas Smad6 acts to regulate
axon outgrowth.
I-Smads act later in development than Bmpr signaling to modulate
dorsal cell fate
A noteworthy feature of our studies is that the effect of mis-
expressing the I-Smads on cell fate is temporally dependent. Thus, we
observed severe defects when the I-Smads were electroporated at HH
stages 14–16 and modest to no defects when they were mis-expressed
approximately 12 h earlier at HH stages 10–12. In contrast, in our
previous studies, we found that constitutively active type I Bmprs
(caBmprIs) are able to reprogram the dorsal spinal cord towards the
dorsal-most fates onlywhen ubiquitously expressed atHHstages 10–12
(Yamauchi et al., 2008). By HH stages 14/15, the mis-expression of
caBmprIs had no effect on the fate of dorsal spinal neurons, but did have
a profound effect on the extent of axon outgrowth (Yamauchi et al.,
2008). Thus, the time frame over which the fate of dP1–dP3 cells can be
re-speciﬁed by the I-Smads is later than the time frame over which the
type I Bmprs can modulate fate in these cells. This result infers that, in
the context of cell fate, the I-Smads are unlikely to act by directly
blocking the functionof the type I Bmprs in dI4–dI6 neurons, rather they
act after the role of the type I Bmprs is over.
Our previous studies suggested that the “window” of competence
during which the type I Bmprs can specify dorsal cell fate closes by HH
stages 14/15 (Yamauchi et al., 2008). Although we have not identiﬁed
when this window closes for I-Smad signaling, our results suggest that
it does not open if dorsal spinal neurons are exposed to I-Smads too
early in development. We had initially predicted that the earlier
I-Smads were mis-expressed during development, the stronger their
effect would be on the acquisition of cell fate. However, dorsal neural
progenitors in the HH stage 10–12 spinal cord are, in fact, largely
impervious to the ectopic expression of the I-Smads. Moreover the
progenitors remain resistant, even though the expression of the
I-Smads presumably persists a further 12 h until the spinal cord
reaches HH stages 14–16, resulting in no change in the activity of the
R-Smads by HH stages 24/25. In contrast, if the I-Smads, particularly
Smad7, is electroporated into HH stages 14–16 spinal cords, dorsal
cells are now competent to respond to the I-Smads, resulting in the
loss of the most dorsal spinal cell fates and an increase in the number
of dI4–dI6 neurons. These results are not a consequence of differences
in the levels of I-Smad expression after electroporation at HH stages
10–12 and HH stages 14–16; the I-Smads were equivalently
expressed at both stages. Rather, it appears that the window of
competence must also open for dorsal cells to be able to respond to
the I-Smads and that persistent early expression of the I-Smads
results in the failure of that window to open.
Smad7 may function in the speciﬁcation of dI4–dI6 fate
Our studies indicate that both of the I-Smads can function to block
the speciﬁcation of dorsal spinal neurons. However, Smad6 only affects
20% of dI1 neurons whereas the ectopic expression of Smad7 results in
the loss of large numbers of dI1 and dI3 neurons. Moreover, the mis-
expressionof Smad7, butnot Smad6, resulted in the formationof ectopic
Cash1/Ngn2+neural progenitors andPax2+neurons in thedorsal-most
region of spinal cord. The remainder of the spinal cord appeared to
develop normally with no change in the number of Mafb+ roof plate
cells, Pax3+ and Pax6+ neural progenitors and Pax2+ dI6-v1 neurons.
These results suggest that the neurons that would have adopted a dI1–
dI3 fate under the inﬂuence of signals from the roof plate, instead
becamedI4–dI6neurons, thedorsal neurons that form independently of
signals fromthe roofplate. Theprecise identityof theectopicNgn2+and
Pax2+ neurons remains unclear. They formed closest to the position
of the Pax2+ dI4 neurons, however in this case the location of the cellbodies along the dorsal–ventral axis of the spinal cord may not be
indicative of their identity. Additionally, the number of ectopic
Ngn2+/Pax2+ neurons does not account for the number of dI1 and
dI3 neurons lost after Smad7 electroporation. On average, after
Smad7 mis-expression, 20–25 dI1 neurons and 10 dI3 neurons were
lost, however an average of only ﬁve ectopic Pax2+ cells were
observed. It seems unlikely that the presumptive dI1/dI3 cells died:
there was no increase in apoptotic cell death and the overall number
of Sox2+ neural progenitors and p27+ neurons did not decrease.
Thus, Smad7 does not interfere with the ability of BMP signaling to
facilitate neurogenesis (Shi and Liu, 2011) rather, the Smad7+ cells
continued to manifest general dorsal characteristics: they expressed
Pax3 and Msx1/2, markers of the dorsal spinal cord (Goulding et al.,
1991), but not Pax6 (Ericson et al., 1997) or Dbx1 (Pierani et al., 2001)
markers of intermediate and ventral spinal fates (Fig. 3 and data not
shown). It is possible that the presumptive dI1/dI3 cells were
undetermined with respect to their identity and as development
proceeded, more of them would have converted to a Pax2+ fate.
Our studies have shed some light on themechanistic basis by which
Smad6 and Smad7 inhibit dI1 and dI3 fate. Both BMP and activin
signaling are important in the establishment of dorsal spinal cord
identity (Liem et al., 1997; Timmer et al., 2005). Studies in vitro have
suggested that Smad6 primarily inhibits BMP signaling (Goto et al.,
2007)whereas Smad7non-speciﬁcally blocks signalingwithin theTGFβ
superfamily (Mochizuki et al., 2004) as well as regulating β-catenin
(Han et al., 2006; Tang et al., 2008). Our in vivo studies examining the
effect of the I-Smads on cell fate are consistent with this model; Smad6
may be less effective at inhibiting the dorsal-most cell fates because it
only blocks BMP signaling, in contrast Smad7 can inhibit BMP, activin
and Wnt signaling. Supporting this model, Smad6 has no effect on the
dI3 fate, which has been shown to be dependent on activin signaling
(Timmer et al., 2005). That Smad7 acts to modulate cell fate decisions
some 12 h after the action of type I Bmpr signaling suggests that, in this
case, Smad7 does not directly inhibit type I Bmpr signaling, but rather
interferes with formation of the trimeric Smad complex (Zhang et al.,
2007) or works in combination with Smurf1, a E3 ubiquitin protein
ligase that targets the receptor complex for degradation (Ebisawa et al.,
2001;Murakami et al., 2003). In either case, the ability of Smad7 toblock
BMP/TGFβ signaling locally in the intermediate spinal cordappears tobe
critical for the assumption of dI4–dI6 fate.
Smad6 regulates dI1 axon outgrowth
Our previous studies have demonstrated that the roof plate BMPs
can also act as a chemorepellent, guiding dI1 commissural axons away
from the dorsal midline (Augsburger et al., 1999; Butler and Dodd,
2003). We initially concentrated on the ability of the BMPs to orient
dI1 axons, however our subsequent studies have shown that the BMPs
also act to regulate the rate of dI1 axon growth as they grow through
the dorsal spinal cord (Phan et al., 2010). These studies focused on the
role of a non-canonical effector of BMP signaling Lim domain kinase
(Limk) 1 acting locally to slow axon extension in the dorsal spinal
cord. If the rate of outgrowth was not correctly regulated, dI1 axons
made errors in their guidance decisions (Phan et al., 2010). Thus, the
ability of the BMPs to control the rate of dI1 axon outgrowth is critical
for stereotyped circuit formation. Moreover, an unusual topographical
feature of the dI1 neurons is that their cell bodies remain near the
source of BMPs for some days, thus in theory allowing BMP signaling
to have a lingering effect on dI1 axon growth beyond the trajectory in
the dorsal spinal cord.
Here we show that Smad6 is expressed in HH stage 27 post-mitotic
migrating dI1 neurons (Fig. 1G) and Smad6 protein is present at high
levels in contralaterally projecting dI1 axons (Figs. 1J–L). When Smad6
was mis-expressed at an earlier time in development axon growth was
slowed in vivo, supporting the results from studies showing that the
I-Smads can decrease neurite outgrowth in vitro (Yanagisawa et al.,
574 V.M. Hazen et al. / Developmental Biology 356 (2011) 566–5752001) and that constitutively active or dominantly negative type I
Bmprs inhibit dI1 axon outgrowth (Yamauchi et al., 2008 and KDP and
SJB, unpublished data). Smad6 and the type I Bmprs affect dI1 axon
outgrowth during the same time period, suggesting that Smad6 could
regulate axon outgrowth by interactingwith the type I Bmprs. However,
we are observing the effects of Smad6 up to 40 h after electroporation, a
period of time too long to conclude that Smad6 must act by directly
interfering with BmprI receptor signaling. An alternate model is that
Smad6 blocks the formation of the Smad complex. Smad6 has been
shown to interact with Smad1 in Xenopus (Hata et al., 1998). Our
studies have indicated that Smad6 can effectively inhibit the activity of
the R-Smads (Supplemental Fig. 1A) and that Smad1 is present in neural
processes (VMH and SJB, unpublished data). Recent work has shown
that the activation of Smad1 can promote growth in regenerating axons
(Parikh et al., 2011; Zou et al., 2009). Taken together, these observations
suggest that presence of Smad6 could act to antagonize the intra-axonal
Smad signaling, and thereby modulate axonal growth rate. The role of
the Smads during axon guidance remains to be determined, however
there has been elegant work showing that the R-Smads function as
retrograde signals in the control of synaptic growth and homeostasis
(Ball et al., 2010; Goold and Davis, 2007; McCabe et al., 2003).
Summary
These studies demonstrate a role for the I-Smads in the regulation of
BMP/activin signaling, permitting the effect of BMP/activin signaling to
be limited to speciﬁc areas of the dorsal spinal cord. They further shed
light on functional differences between the action of Smad6 and Smad7
in the developing spinal cord, which permit them to inhibit different
activities of the BMPs.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.ydbio.2011.06.017.
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